Literature DB >> 7909053

Clinical management of Lyme borreliosis.

K Weber1, H W Pfister.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7909053     DOI： 10.1016/s0140-6736(94)90131-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

Review 1.  Bacteria-Triggered reactive arthritis: implications for antibacterial treatment.

Authors:  A Toivanen
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Treatment of Lyme arthritis.

Authors:  M A Cimmino; G L Moggiana; M Parisi; S Accardo
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

Review 3.  Rational prescribing of antibacterials in hospitalised children.

Authors:  J E Hoppe
Journal:  Pharmacoeconomics       Date:  1996-12       Impact factor: 4.981

Review 4.  Rational prescribing of antibacterials in ambulatory children.

Authors:  J E Hoppe
Journal:  Pharmacoeconomics       Date:  1996-12       Impact factor: 4.981

5.  Cerebrospinal fluid-infiltrating CD4+ T cells recognize Borrelia burgdorferi lysine-enriched protein domains and central nervous system autoantigens in early lyme encephalitis.

Authors:  Jan D Lünemann; Harald Gelderblom; Mireia Sospedra; Jacqueline A Quandt; Clemencia Pinilla; Adriana Marques; Roland Martin
Journal:  Infect Immun       Date:  2006-10-23       Impact factor: 3.441

Review 6.  Treatment failure in erythema migrans--a review.

Authors:  K Weber
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

7.  Erythema migrans: three weeks treatment for prevention of late Lyme borreliosis.

Authors:  F Breier; G Kunz; H Klade; G Stanek; E Aberer
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

8.  Polymerase chain reaction control of antibiotic treatment in dermatoborreliosis.

Authors:  R Muellegger; N Zoechling; E M Schluepen; H P Soyer; S Hoedl; M Volkenandt
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

9.  Neuroborreliosis as a cause of respiratory failure.

Authors:  M T Silva; M Sophar; R S Howard; G T Spencer
Journal:  J Neurol       Date:  1995-09       Impact factor: 4.849

10.  PCR-reverse line blot typing method underscores the genomic heterogeneity of Borrelia valaisiana species and suggests its potential involvement in Lyme disease.

Authors:  Edmond Godfroid; Chang Min Hu; Pierre-François Humair; Alex Bollen; Lise Gern
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.